PAS
KRON

Point72 Asia (Singapore)’s Kronos Bio KRON Stock Holding History

Point72 Asia (Singapore)’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,246
Closed -$15.9K – 1277
2024
Q1 		$15.9K Buy
+12,246
New +$14K ﹤0.01% 979

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Point72 Asia (Singapore)'s KRON Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Kronos Bio (KRON) in Q2 2024, closing a stake of 12,246 shares — an estimated $15.9K sold.

Point72 Asia (Singapore) first reported a position in KRON in Q1 2024 and held it in 1 quarter. The position peaked at $15.9K in Q1 2024. 56 funds tracked by Wall St. Rank hold KRON as of Q2 2024.

  • Point72 Asia (Singapore) reported no remaining Kronos Bio position as of Q2 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 12,246 Kronos Bio shares in Q2 2024, an estimated $15.9K.
  • Point72 Asia (Singapore) first reported a position in Kronos Bio in Q1 2024 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s Kronos Bio position peaked at $15.9K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.